Quanterix (NASDAQ:QTRX) Issues Earnings Results, Misses Estimates By $0.63 EPS

Quanterix (NASDAQ:QTRX) posted its quarterly earnings data on Monday. The company reported ($1.04) earnings per share for the quarter, missing the consensus estimate of ($0.41) by ($0.63), FiscalAI reports. The firm had revenue of $32.91 million for the quarter, compared to analysts’ expectations of $37.46 million. Quanterix had a negative return on equity of 23.92% and a negative net margin of 71.86%.

Quanterix Price Performance

Shares of QTRX opened at $4.03 on Monday. The company’s fifty day moving average is $3.70 and its 200-day moving average is $4.20. Quanterix has a 12 month low of $2.39 and a 12 month high of $8.77. The firm has a market cap of $189.85 million, a price-to-earnings ratio of -1.71 and a beta of 1.07.

Wall Street Analysts Forecast Growth

QTRX has been the topic of a number of research analyst reports. TD Cowen lowered their price target on Quanterix from $7.00 to $4.00 and set a “hold” rating on the stock in a report on Thursday, May 7th. Weiss Ratings lowered Quanterix from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. Canaccord Genuity Group lowered their target price on Quanterix from $8.00 to $4.00 and set a “hold” rating on the stock in a research note on Monday, April 20th. Finally, Wall Street Zen upgraded Quanterix from a “sell” rating to a “hold” rating in a report on Saturday, May 9th. Two equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus price target of $4.00.

Hedge Funds Weigh In On Quanterix

Several hedge funds have recently bought and sold shares of the business. Virtu Financial LLC acquired a new stake in shares of Quanterix in the fourth quarter worth about $131,000. Invesco Ltd. lifted its holdings in Quanterix by 14.7% in the 4th quarter. Invesco Ltd. now owns 113,200 shares of the company’s stock worth $720,000 after purchasing an additional 14,508 shares during the last quarter. XTX Topco Ltd lifted its holdings in Quanterix by 555.1% in the 4th quarter. XTX Topco Ltd now owns 74,093 shares of the company’s stock worth $471,000 after purchasing an additional 62,783 shares during the last quarter. Tudor Investment Corp ET AL acquired a new stake in Quanterix in the 4th quarter worth approximately $1,079,000. Finally, Quadrature Capital Ltd bought a new stake in Quanterix during the fourth quarter worth approximately $138,000. 86.48% of the stock is owned by institutional investors and hedge funds.

Quanterix Company Profile

Quanterix Corporation is a life sciences and diagnostics company specializing in ultra-sensitive digital immunoassay platforms. Its proprietary Single Molecule Array (Simoa) technology enables researchers to detect and quantify proteins, peptides and nucleic acids at femtomolar concentrations, offering sensitivity that surpasses traditional immunoassay methods. By translating single-molecule detection into routine laboratory workflows, Quanterix aims to accelerate biomarker discovery and the development of novel diagnostics and therapeutics.

The company’s core product portfolio includes the Simoa HD-1 and HD-X Analyzers, which automate high-throughput digital immunoassays for quantifying low-abundance biomarkers.